NO844879L - Analogifremgangsmaate for fremstilling av terapeutisk aktive indolderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive indolderivater

Info

Publication number: NO844879L
Authority: NO; Norway
Prior art keywords: preparation; therapeutically active; active index; analogy procedure; index derivatives
Prior art date: 1983-12-06

Application number

NO844879A

Other languages

English (en)

Other versions

NO162764C (no

NO162764B (no

Inventor

Alexander William Oxford

Brian Evans

Michael Dennis Dowle

Ian Harold Coates

Original Assignee

Glaxo Group Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-12-06

Filing date

1984-12-06

Publication date

1985-06-07

1984-12-06 Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd

1985-06-07 Publication of NO844879L publication Critical patent/NO844879L/no

1989-11-06 Publication of NO162764B publication Critical patent/NO162764B/no

1990-02-14 Publication of NO162764C publication Critical patent/NO162764C/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/44—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO84844879A 1983-12-06 1984-12-06 Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater. NO162764C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB838332435A GB8332435D0 (en)	1983-12-06	1983-12-06	Chemical compounds

Publications (3)

Publication Number	Publication Date
NO844879L true NO844879L (no)	1985-06-07
NO162764B NO162764B (no)	1989-11-06
NO162764C NO162764C (no)	1990-02-14

Family

ID=10552845

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO84844879A NO162764C (no)	1983-12-06	1984-12-06	Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater.

Country Status (27)

Country	Link
US (1)	US4994483A (no)
JP (2)	JPH062733B2 (no)
KR (1)	KR850004459A (no)
CN (2)	CN85104233A (no)
AT (1)	AT381934B (no)
AU (1)	AU575365B2 (no)
BE (1)	BE901224A (no)
CA (1)	CA1233183A (no)
CH (1)	CH663411A5 (no)
CY (1)	CY1562A (no)
DE (1)	DE3444572C2 (no)
DK (2)	DK583684A (no)
ES (2)	ES8607234A1 (no)
FI (1)	FI80260C (no)
FR (1)	FR2555987B1 (no)
GB (2)	GB8332435D0 (no)
HK (1)	HK85690A (no)
HU (2)	HU196752B (no)
IL (1)	IL73756A (no)
IT (1)	IT1178268B (no)
NL (1)	NL8403719A (no)
NO (1)	NO162764C (no)
NZ (1)	NZ210469A (no)
PT (1)	PT80572B (no)
SE (1)	SE458446B (no)
SG (1)	SG65790G (no)
ZA (1)	ZA849498B (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8332437D0 (en) *	1983-12-06	1984-01-11	Glaxo Group Ltd	Chemical compounds
GB8419575D0 (en) *	1984-08-01	1984-09-05	Glaxo Group Ltd	Chemical compounds
US4785016A (en) *	1984-12-04	1988-11-15	Glaxo Group Limited	Indole derivatives
GB8430624D0 (en) *	1984-12-04	1985-01-09	Glaxo Group Ltd	Chemical compounds
GB8600397D0 (en) *	1986-01-08	1986-02-12	Glaxo Group Ltd	Chemical compounds
US5270333A (en) *	1986-01-28	1993-12-14	Glaxo Group Limited	Indole derivatives
GB8601959D0 (en) *	1986-01-28	1986-03-05	Glaxo Group Ltd	Indole derivatives
GB8719167D0 (en) *	1987-08-13	1987-09-23	Glaxo Group Ltd	Chemical compounds
PH24976A (en) *	1987-08-13	1990-12-26	Glaxo Group Ltd	Indole derivatives
US5225431A (en) *	1987-10-23	1993-07-06	Burroughs Wellcome Co.	Therapeutic substituted indole compounds and compositions thereof
JPH01312506A (ja) *	1988-06-13	1989-12-18	Mitsui Petrochem Ind Ltd	カラーフィルター
CZ288351B6 (en) *	1990-06-07	2001-05-16	Astrazeneca Ab	Nitrogenous heterocyclic compound, process of its preparation and use as well as a medicament containing thereof
GB9209882D0 (en) *	1992-05-07	1992-06-24	Glaxo Lab Sa	Compositions
GB9211277D0 (en)	1992-05-28	1992-07-15	Glaxo Group Inc	Pharmaceutical compositions
ES2055651B1 (es) *	1992-07-20	1995-03-01	Vita Invest Sa	Procedimiento para la obtencion de nuevas amidinas derivadas de 3-aminoetilindoles.
RU2108326C1 (ru) *	1993-02-26	1998-04-10	Вита-Инвест С.А.	Способ получения 2-карбокси-3-[2-(диметиламино)этил]-n-метил-1h-индол-5-метансульфонамида или его сложных эфиров
IT1264813B1 (it) *	1993-07-28	1996-10-10	Oxon Italia Spa	Procedimento per la preparazione di alcansolfonammidi
EP0875513A1 (en) *	1997-04-14	1998-11-04	Eli Lilly And Company	Substituted heteroaromatic 5-HT 1F agonists
US7189753B1 (en)	1997-11-06	2007-03-13	Cady Roger K	Preemptive prophylaxis of migraine
GB9926250D0 (en) *	1999-11-06	2000-01-12	Knoll Ag	Chemical process
US6685951B2 (en)	2001-07-05	2004-02-03	R. T. Alamo Ventures I, Inc.	Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030017175A1 (en) *	2001-07-05	2003-01-23	R.T. Alamo Ventures I, Inc.	Sublingual administration of dihydroergotamine for the treatment of migraine
US20030198669A1 (en) *	2001-07-05	2003-10-23	R.T. Alamo Ventures I, Llc	Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
CA2508290C (en) *	2002-12-20	2017-02-28	Ciba Specialty Chemicals Holding Inc.	Synthesis of amines and intermediates for the synthesis thereof
US20070054953A1 (en) *	2003-05-12	2007-03-08	Potluri Ramesh B	A novel process for preparation of indole derivatives
US20060002989A1 (en) *	2004-06-10	2006-01-05	Ahmed Salah U	Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
ATE489138T1 (de)	2005-04-13	2010-12-15	Neuraxon Inc	Substituierte indolverbindungen mit nos-hemmender aktivität
ZA200809659B (en) *	2006-04-13	2010-03-31	Neuraxon Inc	1,5 and 3,6-substituted indole compounds having NOS inhibitory activity
WO2008056378A2 (en) *	2006-11-09	2008-05-15	Natco Pharma Limited	Novel process for the preparation of naratriptan hydrochloride
PL2425820T3 (pl) *	2007-02-11	2015-08-31	Map Pharmaceuticals Inc	Sposób terapeutycznego stosowania dhe w celu umożliwienia szybkiego złagodzenia migreny przy jednoczesnym zminimalizowaniu profilu działań niepożądanych
US20090163451A1 (en) *	2007-11-16	2009-06-25	Frank Porreca	Methods for treating visceral pain
WO2009062318A1 (en) *	2007-11-16	2009-05-22	Neuraxon, Inc.	3,5-substituted indole compounds having nos and norepinephrine reuptake inhibitory activity
EA201000808A1 (ru)	2007-11-16	2011-04-29	Ньюраксон, Инк.	Индольные соединения и способы лечения висцеральной боли
US20110171141A1 (en) *	2009-06-26	2011-07-14	Kellerman Donald J	Administration of dihydroergotamine mesylate particles using a metered dose inhaler
NZ599344A (en)	2009-09-25	2015-02-27	Reddy’S Lab Ltd Dr	Formulations comprising triptan compounds
US11337962B2 (en)	2009-09-25	2022-05-24	Upsher-Smith Laboratories, Llc	Formulations comprising triptan compounds
CN103619805A (zh) *	2011-05-27	2014-03-05	国立大学法人德岛大学	苄胺衍生物
DK2734634T3 (da)	2011-07-22	2019-10-21	Univ Chicago	Igf-1 til anvendelse til behandling af migræne
CN102827062A (zh) *	2012-09-17	2012-12-19	扬子江药业集团四川海蓉药业有限公司	苹果酸阿莫曲坦的制备方法
EP2935280A4 (en)	2012-12-21	2016-05-25	Map Pharmaceuticals Inc	8'-HYDROXY-DIHYDROERGOTAMINE COMPOUNDS AND COMPOSITIONS

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3322787A (en) *	1964-09-25	1967-05-30	Merck & Co Inc	Alpha-hydrazino-beta-(3-indolyl) alkanoic acid derivatives
US3472870A (en) *	1966-08-29	1969-10-14	Mead Johnson & Co	Sulfonamidotryptamines
US3468882A (en) *	1966-10-07	1969-09-23	Sterling Drug Inc	Phenylhydrazone derivatives as intermediates for preparing indoles
IT1036004B (it) *	1968-05-21	1979-10-30	Abc Ist Biolog Chem Spa	Acidt 3 indolil adetoidrossamici
US3730723A (en) *	1971-06-17	1973-05-01	Eastman Kodak Co	Direct positive processes utilizing silver halide surface image emulsions containing desensitizers
US4283410A (en) *	1978-06-15	1981-08-11	Miles Laboratories, Inc.	3-Amino or amido-2-(1H-indol-3-yl) propanoic acid derivatives
ZA795239B (en) *	1978-10-12	1980-11-26	Glaxo Group Ltd	Heterocyclic compounds
ZW19381A1 (en) *	1980-08-12	1983-03-09	Glaxo Group Ltd	Heterocyclic compounds
ES8301210A1 (es) *	1980-08-12	1982-12-01	Glaxo Group Ltd	Un procedimiento para la preparacion de un derivado del indol.
DK157995C (da) *	1980-08-12	1990-08-06	Glaxo Group Ltd	Analogifremgangsmaade til fremstilling af indolderivater
GR79215B (no) *	1982-06-07	1984-10-22	Glaxo Group Ltd
GB8332437D0 (en) *	1983-12-06	1984-01-11	Glaxo Group Ltd	Chemical compounds
US4785016A (en) *	1984-12-04	1988-11-15	Glaxo Group Limited	Indole derivatives

1983
- 1983-12-06 GB GB838332435A patent/GB8332435D0/en active Pending
- 1983-12-06 HU HU834168A patent/HU196752B/hu unknown
1984
- 1984-12-05 FI FI844789A patent/FI80260C/fi not_active IP Right Cessation
- 1984-12-06 GB GB08430810A patent/GB2150932B/en not_active Expired
- 1984-12-06 JP JP59258409A patent/JPH062733B2/ja not_active Expired - Lifetime
- 1984-12-06 AU AU36367/84A patent/AU575365B2/en not_active Ceased
- 1984-12-06 NO NO84844879A patent/NO162764C/no unknown
- 1984-12-06 ES ES538336A patent/ES8607234A1/es not_active Expired
- 1984-12-06 IT IT49265/84A patent/IT1178268B/it active
- 1984-12-06 CH CH5810/84A patent/CH663411A5/fr not_active IP Right Cessation
- 1984-12-06 AT AT0387384A patent/AT381934B/de not_active IP Right Cessation
- 1984-12-06 NZ NZ210469A patent/NZ210469A/xx unknown
- 1984-12-06 BE BE0/214125A patent/BE901224A/fr not_active IP Right Cessation
- 1984-12-06 FR FR8418618A patent/FR2555987B1/fr not_active Expired
- 1984-12-06 NL NL8403719A patent/NL8403719A/nl not_active Application Discontinuation
- 1984-12-06 SE SE8406200A patent/SE458446B/sv not_active IP Right Cessation
- 1984-12-06 KR KR1019840007709A patent/KR850004459A/ko not_active Ceased
- 1984-12-06 CA CA000469528A patent/CA1233183A/en not_active Expired
- 1984-12-06 DE DE3444572A patent/DE3444572C2/de not_active Expired - Fee Related
- 1984-12-06 ZA ZA849498A patent/ZA849498B/xx unknown
- 1984-12-06 DK DK583684A patent/DK583684A/da not_active Application Discontinuation
- 1984-12-06 IL IL73756A patent/IL73756A/xx unknown
1985
- 1985-05-30 HU HU852083A patent/HUT40624A/hu unknown
- 1985-05-31 PT PT80572A patent/PT80572B/pt not_active IP Right Cessation
- 1985-06-03 CN CN198585104233A patent/CN85104233A/zh active Pending
- 1985-08-19 CN CN85106225A patent/CN1015055B/zh not_active Expired
- 1985-09-02 ES ES546631A patent/ES8800150A1/es not_active Expired
1989
- 1989-11-30 US US07/443,874 patent/US4994483A/en not_active Expired - Fee Related
1990
- 1990-08-06 SG SG65790A patent/SG65790G/en unknown
- 1990-09-06 DK DK214090A patent/DK214090A/da not_active Application Discontinuation
- 1990-10-18 HK HK856/90A patent/HK85690A/xx not_active IP Right Cessation
- 1990-11-29 JP JP2326200A patent/JPH03184958A/ja active Pending
1991
- 1991-05-17 CY CY1562A patent/CY1562A/en unknown

Also Published As

Publication number	Publication date
FI844789A0 (fi)	1984-12-05
NO162764C (no)	1990-02-14
DK583684D0 (da)	1984-12-06
GB2150932A (en)	1985-07-10
GB8332435D0 (en)	1984-01-11
SE8406200L (sv)	1985-06-07
JPS60155156A (ja)	1985-08-15
IT1178268B (it)	1987-09-09
FI80260B (fi)	1990-01-31
FR2555987A1 (fr)	1985-06-07
ATA387384A (de)	1986-05-15
BE901224A (fr)	1985-06-06
HUT36455A (en)	1985-09-30
HU196752B (en)	1989-01-30
AU575365B2 (en)	1988-07-28
ZA849498B (en)	1986-09-24
DK214090D0 (da)	1990-09-06
CY1562A (en)	1991-05-17
NO162764B (no)	1989-11-06
SG65790G (en)	1990-10-26
PT80572B (en)	1986-12-22
IL73756A0 (en)	1985-03-31
CN85104233A (zh)	1987-01-07
GB2150932B (en)	1987-10-28
IL73756A (en)	1988-02-29
CN85106225A (zh)	1987-02-18
DE3444572A1 (de)	1985-06-20
SE458446B (sv)	1989-04-03
AT381934B (de)	1986-12-10
PT80572A (en)	1985-06-01
IT8449265A0 (it)	1984-12-06
ES8800150A1 (es)	1987-10-16
FI80260C (fi)	1990-05-10
CN1015055B (zh)	1991-12-11
US4994483A (en)	1991-02-19
DK214090A (da)	1990-09-06
KR850004459A (ko)	1985-07-15
JPH062733B2 (ja)	1994-01-12
NL8403719A (nl)	1985-07-01
ES538336A0 (es)	1986-06-01
ES546631A0 (es)	1987-10-16
HK85690A (en)	1990-10-25
DE3444572C2 (de)	1993-10-14
SE8406200D0 (sv)	1984-12-06
GB8430810D0 (en)	1985-01-16
HUT40624A (en)	1987-01-28
ES8607234A1 (es)	1986-06-01
DK583684A (da)	1985-06-07
CA1233183A (en)	1988-02-23
AU3636784A (en)	1985-06-13
NZ210469A (en)	1989-01-27
JPH03184958A (ja)	1991-08-12
FI844789L (fi)	1985-06-07
CH663411A5 (fr)	1987-12-15
FR2555987B1 (fr)	1987-07-17

Publication	Publication Date	Title
NO841568L (no)	1984-10-19	Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater
NO161372C (no)	1989-08-09	Analogifremgangsmaate for fremstilling av terapeutisk aktive guaninderivater.
NO843979L (no)	1985-04-09	Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater
NO151966C (no)	1985-07-10	Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazol-5-eddiksyrederivater
NO171638C (no)	1993-04-14	Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin-derivater
NO820479L (no)	1982-08-18	Fremgangsmaate for fremstilling av terapeutisk aktive carbostyrilderivater
NO162764C (no)	1990-02-14	Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater.
NO165192C (no)	1991-01-09	Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO814136L (no)	1982-06-07	Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-arylalkyl-3-fenyl-3-notropanol-derivater
NO164301C (no)	1990-09-19	Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO168355C (no)	1992-02-12	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO168362C (no)	1992-02-12	Analogifremgangsmaate for fremstilling av terapeutisk aktive peptidforbindelser
NO167569C (no)	1991-11-20	Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO159930C (no)	1989-02-22	Analogifremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater.
NO161562C (no)	1989-08-30	Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO158941C (no)	1988-11-16	Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO165842C (no)	1991-04-17	Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser.
NO833527L (no)	1984-04-02	Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater
NO151285C (no)	1985-03-13	Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO151196C (no)	1985-02-27	Analogifremgangsmaate for fremstilling av terapeutisk virksomme fluorerte alkenylendiaminderivater
NO158673C (no)	1988-10-19	Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater.
NO167923C (no)	1991-12-27	Analogifremgangsmaate for fremstilling av terapeutisk aktive peptidsubstituerte heterocykliske forbindelser
NO820112L (no)	1982-07-19	Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater
NO813821L (no)	1982-05-13	Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater
NO158376C (no)	1988-08-31	Analogifremgangsmaate for fremstilling av terapeutisk virksomme rooperolforbindelser.